Literature DB >> 1496057

Facial emotion discrimination: III. Behavioral findings in schizophrenia.

C Heimberg1, R E Gur, R J Erwin, D L Shtasel, R C Gur.   

Abstract

Emotional discrimination was studied in patients with schizophrenia (n = 20) and matched controls. Performance of the emotion-discrimination tasks in the schizophrenic patients was impaired, relative to their performance of an age-discrimination task. Performance patterns in the patient group could also be reliably distinguished from those of normal controls. The impairment was associated with the severity of both emotional and nonemotional symptoms specific to schizophrenia, but not with the severity of nonspecific symptoms. The deficit associated with schizophrenia is more marked than that reported for depression (Gur et al., 1992), particularly for the emotion-discrimination tasks, and showed no difference between "happy" discrimination and "sad" discrimination. The main difficulty in patients with schizophrenia is the assignment of emotional valence to neutral faces. The magnitude of the deficit underscores the salience of emotional impairment in schizophrenia, and its relation to cognitive dysfunction in this disorder merits further scrutiny.

Entities:  

Mesh:

Year:  1992        PMID: 1496057     DOI: 10.1016/0165-1781(92)90117-l

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  44 in total

1.  Visual evoked potentials in humans during recognition of emotional facial expressions.

Authors:  E S Mikhailova; D V Davydov
Journal:  Neurosci Behav Physiol       Date:  1999 Nov-Dec

Review 2.  Processing faces and facial expressions.

Authors:  Mette T Posamentier; Hervé Abdi
Journal:  Neuropsychol Rev       Date:  2003-09       Impact factor: 7.444

3.  Computerized measurement of facial expression of emotions in schizophrenia.

Authors:  Christopher Alvino; Christian Kohler; Frederick Barrett; Raquel E Gur; Ruben C Gur; Ragini Verma
Journal:  J Neurosci Methods       Date:  2007-03-12       Impact factor: 2.390

4.  Amygdala abnormalities in first-degree relatives of individuals with schizophrenia unmasked by benzodiazepine challenge.

Authors:  Daniel H Wolf; Theodore D Satterthwaite; James Loughead; Amy Pinkham; Eve Overton; Mark A Elliott; Gersham W Dent; Mark A Smith; Ruben C Gur; Raquel E Gur
Journal:  Psychopharmacology (Berl)       Date:  2011-05-21       Impact factor: 4.530

5.  A female advantage in basic face recognition is absent in schizophrenia.

Authors:  Ryan McBain; Daniel Norton; Yue Chen
Journal:  Psychiatry Res       Date:  2010-03-25       Impact factor: 3.222

6.  Electrophysiological responses to affective stimuli in Mexican Americans: Relationship to alcohol dependence and personality traits.

Authors:  José R Criado; Cindy L Ehlers
Journal:  Pharmacol Biochem Behav       Date:  2007-08-10       Impact factor: 3.533

7.  Sex differences, hormones, and fMRI stress response circuitry deficits in psychoses.

Authors:  Jill M Goldstein; Katie Lancaster; Julia M Longenecker; Brandon Abbs; Laura M Holsen; Sara Cherkerzian; Susan Whitfield-Gabrieli; Nicolas Makris; Ming T Tsuang; Stephen L Buka; Larry J Seidman; Anne Klibanski
Journal:  Psychiatry Res       Date:  2015-03-31       Impact factor: 3.222

8.  Symptom correlates of static and dynamic facial affect processing in schizophrenia: evidence of a double dissociation?

Authors:  Patrick J Johnston; Peter G Enticott; Angela K Mayes; Kate E Hoy; Sally E Herring; Paul B Fitzgerald
Journal:  Schizophr Bull       Date:  2008-10-26       Impact factor: 9.306

Review 9.  Multimodal Brain and Behavior Indices of Psychosis Risk.

Authors:  Ruben C Gur
Journal:  Nebr Symp Motiv       Date:  2016

10.  Low voltage alpha EEG phenotype is associated with reduced amplitudes of alpha event-related oscillations, increased cortical phase synchrony, and a low level of response to alcohol.

Authors:  Cindy L Ehlers; Derek N Wills; Evelyn Phillips; James Havstad
Journal:  Int J Psychophysiol       Date:  2015-07-04       Impact factor: 2.997

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.